跳至主要内容
临床试验/DRKS00014353
DRKS00014353招募中1 期

Prospective, monocentric, open, one-arm clinical Phase I/IIa study regarding safety and predictive capacity of two-time topical application of FITC-adalimumab as an in-vivo diagnostic tool in combination with confocal laser endomicroscopy in ulcerative colitis patients with indication for anti-TNF antibody adalimumab therapy - MAgIC (MoleculAr imaging In ulcerative Colitis)

Medizinische Fakultät der Friedrich-Alexander-Universität Erlangen-Nürnberg Dekanat0 个研究点目标入组 25 人开始时间: 2018年3月29日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • Patients with moderate-to-sever ulcerative colitis and indication for therapy with the anti-TNF antibody adalimumab

排除标准

  • - Undefined colitis, including differential diagnosis of Crohn's disease, ischemic colitis, infectious colitis.
  • - Stenosis due to ulcerative colitis
  • - Fulminat ulcerative colitis
  • - Toxic megacolon
  • - Colectomy
  • - Ileo-anal Pouch or ileo-rectosomie or ileostoma

研究者

发起方
Medizinische Fakultät der Friedrich-Alexander-Universität Erlangen-Nürnberg Dekanat

相似试验